Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -293,618 | -210,077 | -112,976 | -444,037 | -327,658 |
| Depreciation Amortization | 23,418 | 15,937 | 7,572 | 29,522 | 21,535 |
| Income taxes - deferred | -4,387 | -2,866 | -1,408 | -3,479 | -1,720 |
| Accounts receivable | -55,617 | -31,453 | -83 | -149 | N/A |
| Accounts payable and accrued liabilities | -1,769 | -16,205 | -5,815 | 4,828 | -6,595 |
| Other Working Capital | -83,565 | -71,260 | -32,549 | -6,521 | -18,409 |
| Other Operating Activity | 135,857 | 95,216 | 22,980 | 58,016 | 54,997 |
| Operating Cash Flow | $-279,681 | $-220,708 | $-122,279 | $-361,820 | $-277,850 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -60,614 | -14,101 | -54,762 | 79,681 | 149,250 |
| PPE Investments | -6,901 | -4,613 | -4,171 | -22,290 | -18,761 |
| Net Acquisitions | -52,573 | -52,573 | -52,573 | -212,633 | -212,886 |
| Investing Cash Flow | $-120,088 | $-71,287 | $-111,506 | $-155,242 | $-82,397 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 400,333 | 352,102 | 198,277 | 465,754 | 464,606 |
| Other Financing Activity | -11,978 | -5,701 | -4,701 | -2,795 | -2,609 |
| Financing Cash Flow | $388,355 | $346,401 | $193,576 | $462,959 | $461,997 |
| Exchange Rate Effect | 637 | -616 | -491 | -2,740 | -5,761 |
| Beginning Cash Position | 181,318 | 181,318 | 181,318 | 238,161 | 238,161 |
| End Cash Position | 170,541 | 235,108 | 140,618 | 181,318 | 334,150 |
| Net Cash Flow | $-10,777 | $53,790 | $-40,700 | $-56,843 | $95,989 |
| Free Cash Flow | |||||
| Operating Cash Flow | -279,681 | -220,708 | -122,279 | -361,820 | -277,850 |
| Capital Expenditure | -6,901 | -4,613 | -4,171 | -22,290 | -18,761 |
| Free Cash Flow | -286,582 | -225,321 | -126,450 | -384,110 | -296,611 |